Friday, July 04, 2025 | 07:09 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Cohance Lifesciences Share Price

Know More
BSENSE

1,006.65 36.90 (3.81%)

04:01 PM, 3-Jul-2025

1,007.40 39.60 (4.09%)

03:48 PM, 3-Jul-2025

BSE : 543064

NSE : COHANCE

Sector : Health care

ISIN Code : INE03QK01018

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 03-Jul-2025 | 09:31 PM IST

Market Cap (₹ Cr.)

38,514

Traded Value (₹ Cr)

1.45

Volume (Shares)

14,382

Face Value (₹)

1

52-Week High (₹)

1,359.00

52-Week High Date

02-Dec-2024

52-Week Low (₹)

789.10

52-Week Low Date

08-Jul-2024

All Time High (₹)

1,359.00

All Time High Date

02-Dec-2024

All Time Low (₹)

87.05

All Time Low Date

24-Mar-2020

Cohance Lifesciences Ltd

Suven Pharmaceuticals Limited (SPL) is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors. The Company's comprehensive services encompass- Custom Synthesis Process R&DScale-Up and Contract Manufacturing of intermediates APIs and formulations. Suven Pharmace...
Read More
BSE
NSE

Cohance Lifesciences Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr.)

38,543

EPS - TTM (₹) [C]

7.00

P/E Ratio (X) [C]

143.91

Face Value (₹) 1
Latest Dividend (%)100.00
Latest Dividend Date 09-Sep-2022
Dividend Yield (%) -
Book Value Share (₹) [C]44.68
P/B Ratio (₹) [C]22.55

Funds Owning this Stock

Load more

Research Reports

DateBrokerActionPrices(₹) Report
24-Mar-2025ICICI Securities Buy 1,400

Stock Strength

Today's Low/High (₹)

968.75

1,016.95

Week Low/High (₹)

930.30

1,016.95

Month Low/High (₹)

930.30

1,073.00

Year Low/High (₹)

789.10

1,360.00

All time Low/High (₹)

87.05

1,360.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week0.53%0.54%-0.62%-0.56%
1 Month-0.55%-0.67%3.10%3.52%
3 Month-10.47%-10.47%9.10%9.27%
6 Month-8.89%-8.56%5.07%5.83%
1 Year21.84%22.15%4.07%4.61%
3 Year118.24%117.86%57.33%61.28%

Company Info

Company Information

Non Executive Director : Shweta Jalan

Independent Director : U B Pravin Rao

Managing Director : Venkatanaga Kali Vara Prasad Raju Vetukuri

Non Executive Director : Pankaj Patwari

Independent Director : Matangi Gowrishankar

Independent Director : Vinod Rao

Independent Director : K G Ananthakrishnan

Executive Chairman & Director : VIVEK SHARMA

Company Sec. & Compli. Officer : Kundan Kumar Jha

Additional Director : Jaishankar Krishnan

Additional Director : Vinod Padikkal

Registered Office: 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5,Hyderabad,Telangana-500034 Ph: 91-40-23549414/1142/3311

Email:khrao@suvenpharm.com

URL:http://www.suvenpharm.com

FAQs about Cohance Lifesciences Ltd

1. What's the Cohance Lifesciences Ltd share price today?
Cohance Lifesciences Ltd share price was Rs 1,006.65 at 04:01 PM IST on 3rd Jul 2025. Cohance Lifesciences Ltd share price was up by 3.81% over the previous closing price of Rs 969.75. Cohance Lifesciences Ltd share price trend:

  • Last 1 Month: Cohance Lifesciences Ltd share price moved down by 0.55% on BSE.
  • Last 3 Months: Cohance Lifesciences Ltd share price moved down by 10.47% on BSE.
  • Last 12 Months: Cohance Lifesciences Ltd share price moved up by 21.84% on BSE.
  • Last 3 Years: Cohance Lifesciences Ltd share price moved up by 118.24% on BSE.


2. How can I quickly analyse the performance of the Cohance Lifesciences Ltd stock?
The performance of the Cohance Lifesciences Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 143.91
  • Price to book value ratio is 22.55
  • The EPS (trailing 12 months) of the Cohance Lifesciences Ltd stock is Rs 7.00


3. What is the market cap of Cohance Lifesciences Ltd?
Cohance Lifesciences Ltd has a market capitalisation of Rs 38,514 crore.


4. What is Cohance Lifesciences Ltd's 52-week high/low share price?
The Cohance Lifesciences Ltd’s 52-week high share price is Rs 1,359.00 and 52-week low share price is Rs 789.10.


5. Is the Cohance Lifesciences Ltd profitable?
On a consolidated basis, Cohance Lifesciences Ltd reported a profit of Rs 38.73 crore on a total income of Rs 412.59 crore for the quarter ended 2025. For the year ended 2024, Cohance Lifesciences Ltd had posted a profit of Rs 300.28 crore on a total income of Rs 1,051.35 crore.


6. Which are Cohance Lifesciences Ltd’s peers in the Health care sector?
Cohance Lifesciences Ltd’s top 5 peers in the Health care sector are Glenmark Pharma., Biocon, Laurus Labs, Cohance Life, Ipca Labs., Ajanta Pharma, Gland Pharma.


7. Who owns how much in Cohance Lifesciences Ltd?
Key changes to the Cohance Lifesciences Ltd shareholding are as follows:

  • Promoter holding in Cohance Lifesciences Ltd has gone up to 66.41 per cent as of May 2025 from 50.10 per cent as of Sep 2024.